TRAW
Traws Pharma Inc
NASDAQ: TRAW · HEALTHCARE · BIOTECHNOLOGY
$1.43
+10.00% today
Updated 2026-04-30
Market cap
$11.58M
P/E ratio
1.39
P/S ratio
4.15x
EPS (TTM)
$0.82
Dividend yield
—
52W range
$1 – $3
Volume
0.2M
Traws Pharma Inc (TRAW) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |